Dr. Laurence Paul
Next is news from Valeant Pharmaceuticals International. Dr. Laurence Paul - who served on the Board of Directors at Biovail Corporation in June 2002 and continued to serve as the company merged with Valeant in 2010 - has resigned due to expanded business, philanthropic, and personal commitments.
J. Michael Pearson, Chairman and CEO at Valeant thanked Paul for over a decade of service, adding: “Larry has been a superb Board member for Valeant, investing his valuable time, talent, and passion to help transform Biovail and Valeant into a leading pharmaceutical company. Larry's wise counsel will be missed.”